UK biotechnology group welcomes Bioscience 2015 report

9 February 2009

The UK's BioIndustry Association has welcomed the publication of the Bioscience 2015 Review and Refresh report. The group, which includes the  country's biotechnology drugmakers, said the recommendations build on  those in the original Bioscience 2015 report published in 2003. The new  report was produced by a committee chaired by Sir David Cooksey, which  included biotechnology firms, the finance community, patient groups,  research councils, academia and input from various government  departments.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight